Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group
- 1 January 1981
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 7 (1) , 71-77
- https://doi.org/10.1016/0360-3016(81)90062-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasoneThe British Journal of Radiology, 1980
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- Clinical Phase I Study of the Hypoxic Cell Radiosensitizer RO-07-0582, A 2-Nitroimidazole DerivativeRadiology, 1977
- Radiation and High-Dose Metronidazole in Supratentorial GlioblastomasNew England Journal of Medicine, 1976
- Procarbazine hydrochloride in the treatment of brain tumorsJournal of Neurosurgery, 1974
- Effect of vincristine sulphate on the intracranial gliomata of hildhoodBritish Journal of Surgery, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958